When and in Whom to Initiate HCV Therapy

  • Published 2018

Abstract

Successful hepatitis C treatment results in sustained virologic response (SVR), which is tantamount to virologic cure and, as such, is expected to benefit nearly all chronically infected persons. When the US Food and Drug Administration (FDA) approved the first interferon-sparing treatment for HCV infection, many patients who had previously been “warehoused… (More)

Topics

  • Presentations referencing similar topics